human migration

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

Researchers also found that Neanderthals differed from humans more in the regulatory than protein-coding sequences of their genomes.

A genetic analysis has uncovered what appears to be Converso ancestry among a large cohort of Latin American individuals, Forbes reports.

Using data for almost 10,900 Latino individuals with diverse ancestry, investigators identified distinct patterns for risky or protective APOE variants.

Using sequences from a 4,900-year-old Swedish gravesite, researchers identified a pathogenic form of Yersinia pestis circulating in Europe during the Neolithic Period.

This Week in Nature

In Nature this week: study of human-Neanderthal interbreeding, attention deficit/hyperactivity disorder risk loci reported, and more.

An international team of researchers used ancient and modern genome sequences to examine the admixture and population history of Finland.

A human-Neanderthal admixture event likely occurred before East Asian and European lineages diverged, while later events involved only East Asian or European lineages.

This Week in Science

In Science this week: ancient genomes inform studies of human migration in the Americas, and more.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.